Trump administration to announce drug pricing deals

The Trump administration is preparing to announce new deals regarding drug pricing. These initiatives aim to address the costs of pharmaceutical products through specific agreements. The announcement focuses on implementing strategies to manage drug pricing more effectively across the healthcare system. This move reflects the administration's ongoing efforts to negotiate better terms for medications, ensuring that the reported pricing deals are formalized and communicated to the public as part of their broader healthcare policy goals.